tm logo
FABIOR
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 16 Feb 2009

Last Applicant/ Owned by

Glaxo Wellcome House, Berkeley Avenue

Greenford, Middlesex

GB

UB3 ONN

Serial Number

78438372 filed on 21st Jun 2004

Registration Number

N/A

Correspondent Address

MARIBETH DAY CASE

GLAXOSMITHKLINE

FIVE MOORE DRIVE

MAI-B443

RESEARCH TRIANGLE PARK, NC 27709

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

FABIOR

Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Mark Details


Serial Number

No 78438372

Mark Type

No Service/Collective Mark

Attorney Docket Number

No App / FABIOR

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Feb 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
16th Feb 2009ABANDONMENT - NO USE STATEMENT FILED
02th Jul 2008EXTENSION 5 GRANTED
27th Jun 2008EXTENSION 5 FILED
27th Jun 2008TEAS EXTENSION RECEIVED
26th Jun 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
30th Nov 2007EXTENSION 4 GRANTED
12th Nov 2007TEAS EXTENSION RECEIVED
12th Nov 2007EXTENSION 4 FILED
05th Sep 2007EXTENSION 3 GRANTED